AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling - Wikidata - wikimedia - TriplyDB

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling

http://www.wikidata.org/entity/Q28216932

about

sameAs

Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1 Effects of arachidonic acid supplementation on training adaptations in resistance-trained males Signaling by target of rapamycin proteins in cell growth control Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells Amino acids as regulators of gene expression The TOR pathway comes of age AMP-activated protein kinase, stress responses and cardiovascular diseases 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia.Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy Glycogen availability and skeletal muscle adaptations with endurance and resistance exercise Mitochondria Retrograde Signaling and the UPR mt: Where Are We in Mammals?MYC and the art of microRNA maintenance Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism?Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation An expanded role for AMP-activated protein kinase: regulator of myocardial protein degradation Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review Metabolic shifts during aging and pathology Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease Rapalogs and mTOR inhibitors as anti-aging therapeutics Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis Involvement of phosphorylation of adenosine 5'-monophosphate-activated protein kinase in PTTH-stimulated ecdysteroidogenesis in prothoracic glands of the silkworm, Bombyx mori AMP-activated protein kinase mediates myogenin expression and myogenesis via histone deacetylase 5 Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study Xanthene derivatives increase glucose utilization through activation of LKB1-dependent AMP-activated protein kinase Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise Does phosphorylation of eukaryotic elongation factor eEF2 regulate protein synthesis in ischemic preconditioning?A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy Impaired overload-induced muscle growth is associated with diminished translational signalling in aged rat fast-twitch skeletal muscle Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2 Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium.TOR signaling.

P2860

32699fd9e11501abfffb99e801956bea4f826132

P248

Q21136155-CAD07DA4-AC83-4DF0-8873-03104067AF42 Q21245426-34311768-F3BA-451D-A044-813B4909547E Q24522447-C0B4105C-2A50-4033-8EEC-93B3F80F4D36 Q24548951-335876DE-0AB8-459B-8C1C-3758D805C6A2 Q24562847-E1732BF3-1335-4982-9942-D4334984D6B5 Q24568353-EC403067-E47E-4DF7-AD18-7DAD2F7DA9D7 Q24610297-7F173613-DD4A-4E5F-A465-80047E62AE88 Q24815455-E252F349-D333-47CC-90C5-56A139002327 Q26772002-8C2D14EF-B59E-4931-93F5-365E2B6EAED9 Q26772305-E2451C52-0463-43ED-BF81-F4F128B7CD18 Q26799891-7C296A77-4549-4F86-A873-07429A933A13 Q26825457-7C0412FB-45AD-467E-A1B0-CAFE4CE9586B Q27000625-9F3F6E4F-E349-4E2B-B47A-19D99EC30E48 Q27024703-8E83F1C3-982F-45AB-A237-C1A6CC89C004 Q27026943-15496B01-EF2A-4175-8B62-3CC96EDD0EF5 Q27694688-E427DC30-1F9B-4B8A-8DF1-C59A7C492596 Q28070376-DBC0A74C-62F0-4AD9-AC96-A09F92A5EEF0 Q28088313-7BE27B67-F1EB-4735-83E0-06075E54C50D Q28246959-5ABA46FE-0B56-4868-A9CF-84A084F2A12E Q28256208-E2754DE9-73D3-465C-8EFC-E0A0F9638BBE Q28286510-D41D8DB3-C0BD-4673-9C76-4031E8F295C1 Q28387775-D0F78A5B-9345-4CE0-8A7F-9BE834428F0A Q28484273-EFBA9E05-D49A-49B7-94FB-790B60259073 Q28484287-3D459300-6A23-40EC-99E7-16C41F397A43 Q28484795-489B059C-2C69-48AD-B1E4-33F6384FCF67 Q28484822-D1E172A7-D9FA-4C1E-B667-8FB378CEEB92 Q28487908-A4392E27-DEAA-4C79-A732-E79A6654D0F5 Q28506793-86E28CA7-0C70-4698-9A04-D94BE8378B5C Q28541996-DB1D0025-7ED0-46E3-97B1-BBD6E7E4B300 Q28543206-9D91D37D-6747-410F-A32D-709D94A2E1BA Q28552408-3C2DDFDE-B14E-460F-B8B4-634B10FF8720 Q28565436-969A96B0-A595-4F5C-95A9-4F7C9BEAFFB1 Q28566793-DE845B26-813E-4E4A-A22D-B147CB460436 Q28571508-07A59B07-628C-42D5-967E-6F5F5E44739C Q28580387-C0C8F7EE-7A2B-4B57-AA8A-B63802F95AE6 Q28580464-56C6A878-A613-46F1-B546-57D8DF1423ED Q28582152-D7D954B9-23DC-4E27-968F-8368E31BD5FA Q28582345-F2B0A299-A1E7-42E0-9F95-0882DA9BD810 Q29347101-0897F26D-7428-466B-B894-BB1D7179B9E8 Q30312086-E43F9621-713A-42A1-8847-87F65AA7BCD8

P2860

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling

http://www.wikidata.org/entity/Q28216932

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@ast

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@en

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@nl

type

label

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@ast

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@en

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@nl

prefLabel

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@ast

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@en

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@nl

P1433

Q28216932-2B0E8ABC-53C6-4B3D-BB0E-08A65D92F7A8

P1476

Q28216932-32289F6E-1259-4BBD-9182-6C346BC0873E

P2093

Q28216932-1552D9BA-7E81-4416-8101-541B670E96DA

Q28216932-295BC249-F95A-4D5B-9493-084DF7204C37

Q28216932-B6D8A5DC-6414-406C-9D3E-3BA575CC575A

Q28216932-DD228502-5BDE-4610-A1E4-52F1363470F2

P304

Q28216932-50CBDA59-F731-4E1D-9B32-668C8AC931CD

P31

Q28216932-54282140-78C7-4460-A130-4A0565389353

P3181

Q28216932-31EF8CB1-21BE-4C55-AF1B-F6D4E8A1BE25

P356

Q28216932-FB170AF0-42F1-429B-B7CC-EB1901D752CC

P407

Q28216932-24152335-1CA5-4F78-9E7B-0E9EBFA1CB45

P433

Q28216932-47BC561A-5847-4C55-B9FD-AF34E38884BE

P478

Q28216932-EB24BA12-11A3-402A-98A6-86FFBC868CF7

P577

Q28216932-B899D71B-C8C9-4F09-90D0-FA341DCD4E76

P698

Q28216932-673E92F8-C8F3-4065-9C77-A0ECB486F94A

P3181

P356

P1433

Journal of Biological Chemistry

P1476

AMP-activated protein kinase s ...... of rapamycin (mTOR) signaling

@en

P2093

Douglas R Bolster

http://www.w3.org/2001/XMLSchema#string

Leonard S Jefferson

http://www.w3.org/2001/XMLSchema#string

Scot R Kimball

http://www.w3.org/2001/XMLSchema#string

Stephen J Crozier

http://www.w3.org/2001/XMLSchema#string

P304

23977-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

60499

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.C200171200

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11997383

http://www.w3.org/2001/XMLSchema#string